Nano-X Imaging rises on US FDA clearance for heart device

Nano-X Imaging

21/08/2024 13:45

** U.S.-listed shares of Nano-X Imaging  NNOX.O  rise 2.2%
to $7.29 premarket 
    ** Israel-based medtech company says its subsidiary,
Nanox.AI, has received U.S. FDA clearance for its upgraded heart
device called healthCCSng V2.0
    ** Device helps in identifying patients at high risk of
coronary artery disease
    ** It uses medical imaging data from CT scans to
automatically measure coronary artery calcium, the number one
risk predictor for future cardiovascular event - NNOX 
    ** Up to previous close, stock up 11.93% YTD 

 (Reporting by Sneha S K)
 ((Sneha.SK@thomsonreuters.com;))